Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings

For the quarter ended March 2024, The Beauty Health Company (SKIN) reported revenue of $81.4 million, down 5.7% over the same period last year. EPS came in at -$0.10, compared to -$0.04 in the year-ago quarter.

The reported revenue represents a surprise of +1.59% over the Zacks Consensus Estimate of $80.13 million. With the consensus EPS estimate being -$0.14, the EPS surprise was +28.57%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Beauty Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Geographic Revenue- Americas: $50.30 million versus $46.27 million estimated by two analysts on average.
  • Geographic Revenue- EMEA: $19.10 million versus the two-analyst average estimate of $16.80 million.
  • Geographic Revenue- Asia Pacific: $12 million compared to the $15.51 million average estimate based on two analysts.
  • Delivery Systems Net Sales: $35.80 million versus $33.19 million estimated by three analysts on average.
  • Consumables Net Sales: $45.60 million versus the three-analyst average estimate of $45.96 million.
View all Key Company Metrics for Beauty Health here>>>

Shares of Beauty Health have returned -10.4% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Beauty Health Company (SKIN) : Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.